![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Wednesday, September 30, 2020 3:40:43 PM
1. Stop trial due to safety issues
2. Stop trial due to lack of efficacy
3. Continue trial (144 patients) DMC believes they can reach end points
4. Stop trial because efficacy has been demonstrated, it would be unethical to continue with placebo
All of us, including Dr Javitt, are rooting for #4. We were rooting for it end of August/beginning of September. I didn't think I would be rooting for it again, lol. At the end of today's video JJ showed excitement discussing this.
PROUD MEMBER OF THE WHALES HAIRY BACK CLUB
FEATURED Element79 Gold Corp Provides Update on Nevada Portfolio • Aug 23, 2024 8:00 AM
Maybacks Adds Award Winning Show to Its Lineup Discusses Maybacks Opportunity • AHRO • Aug 22, 2024 11:30 AM
North Bay Resources Announces First Gold Concentrate at Mt. Vernon Gold Mine, Assays 12 oz/ton Gold, 17.5 oz/ton Platinum, and 8 oz./ton Silver, Sierra County, California • NBRI • Aug 22, 2024 10:28 AM
All Things Mobile Analytic, Inc. Reports Major Growth with Over $11 Million in Revenue • ATMH • Aug 22, 2024 7:19 AM
Unitronix Announces Strategic Entry into Cryptocurrency Space • UTRX • Aug 21, 2024 10:00 AM
Mawson Finland Provides Update on Exploration Activities at Rajapalot • MFL • Aug 21, 2024 9:06 AM